contract_award•Awarded Wednesday, October 21, 2026Analyzed

GLAXOSMITHKLINE, LLC: $81.4M Department of Health and Human Services Contract Vehicle

Neutral

Summary

The CDC awarded an $81.4M IDIQ contract to GLAXOSMITHKLINE, LLC for pediatric flu vaccines, supporting routine public health immunization efforts. The contract spans 2025-2027 and is part of ongoing federal investment in vaccine preparedness.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.CDC continues to invest in pediatric flu vaccines with an $81.4M contract.
  • 2.The contract is an IDIQ, allowing for flexible ordering over two years.
  • 3.No publicly traded company is directly linked, but the healthcare sector benefits from such awards.

Market Implications

The pediatric flu vaccine market is a stable segment of the broader vaccine industry. This contract, while not transformative, supports ongoing public health infrastructure. Investors may look for similar awards from the CDC to gauge federal health spending priorities.

Full Analysis

The Department of Health and Human Services, through the Centers for Disease Control and Prevention, has awarded an indefinite delivery/indefinite quantity contract valued at $81.4 million to GLAXOSMITHKLINE, LLC for pediatric flu vaccines. This contract ensures a supply of vaccines for children, a critical component of public health strategy. The contract period runs from December 31, 2025 to February 28, 2027. While the recipient entity is not publicly listed, the contract represents continued federal commitment to infectious disease prevention. The healthcare sector, particularly vaccine development and distribution, benefits from such steady procurement. No specific publicly traded company is identified as the direct beneficiary, but the contract reinforces the importance of vaccine supply chains. Related legislation in the healthcare space, such as bills promoting biosimilars and patient safety, indicate broader congressional focus on health outcomes, though not directly tied to this award. Investors should watch for similar CDC vaccine contracts as indicators of sustained public health spending.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderOct 19, 2026

Advancing Women's Health to Improve Outcomes in All Phases of Life

This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Contract Details

Recipient

GLAXOSMITHKLINE, LLC

Award Amount

$81,430,402

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Disease Control and Prevention

Contract Type

INDEFINITE DELIVERY / INDEFINITE QUANTITY

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →